Targeted Retreatment of Incompletely Resolved COPD Exacerbations With Ciprofloxacin
A. Ritchie (London, United Kingdom), S. Brill (London, United Kingdom), B. Vlies (Liverpool, United Kingdom), L. Finney (London, United Kingdom), J. Allinson (London, United Kingdom), L. Alves-Moreira (London, United Kingdom), P. Walker (Liverpool, United Kingdom), E. Baker (London, United Kingdom), S. Elkin (London, United Kingdom), P. Mallia (London, United Kingdom), G. Donaldson (London, United Kingdom), P. Calverley (Liverpool, United Kingdom), J. Wedzicha (London, United Kingdom)
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Ritchie (London, United Kingdom), S. Brill (London, United Kingdom), B. Vlies (Liverpool, United Kingdom), L. Finney (London, United Kingdom), J. Allinson (London, United Kingdom), L. Alves-Moreira (London, United Kingdom), P. Walker (Liverpool, United Kingdom), E. Baker (London, United Kingdom), S. Elkin (London, United Kingdom), P. Mallia (London, United Kingdom), G. Donaldson (London, United Kingdom), P. Calverley (Liverpool, United Kingdom), J. Wedzicha (London, United Kingdom). Targeted Retreatment of Incompletely Resolved COPD Exacerbations With Ciprofloxacin. 3386
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: